Unknown

Dataset Information

BNT162b2 vaccine effectiveness in chronic kidney disease patients-an observational study.


ABSTRACT:

Background

Chronic kidney disease (CKD) is a risk factor for severe coronavirus disease 2019 (COVID-19). We aimed to evaluate the real-life effectiveness of the BNT162b2 messenger RNA vaccine for a range of outcomes in patients with CKD compared with matched controls.

Methods

Data from Israel's largest healthcare organization were retrospectively used. Vaccinated CKD [estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2] and maintenance dialysis patients were matched to vaccinated controls without CKD (eGFR ≥60 ml/min/1.73 m2) according to demographic and clinical characteristics. Study outcomes included documented infection with severe acute respiratory syndrome coronavirus 2, symptomatic infection, COVID-19-related hospitalization, severe di

SUBMITTER: Bielopolski D 

PROVIDER: S-EPMC9384353 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature